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1. List of abbreviations 
µl micro litre 
APC antigen-presenting cell 
BLAST basic local alignment search tool 
bp base pair 
BSA bovine serum albumin 
CD cluster of differentiation 
cDNA complementary DNA 
CLR C-type lectin receptor 
Conc. concentration 
CRD carbonate recognition domain 
Ct threshold cycle number 
CpG deoxycytidylate-phosphate-deoxyguanylate 
DAMP danger-associated molecular pattern 
DAP diaminopimelic acid 
DC dendritic cell 
DMEM Dulbecco's modified eagle medium 
DNA deoxyribonucleic acid 
dNTP deoxynucleotide triphosphates 
ds/ss double-stranded/single-stranded 
EDTA ethylenediaminetetraacetic acid 
ELISA enzme-linked immunosorbent assay 
EtBr ethidium bromide 
EU endotoxin unit 
FCS fetal calf serum 
FcεRI/II high-affinity receptor for IgE 
g (ng, pg) gram (nanogram, pictogram) 
g gravity 
h hour 
IFN interferon 
Ig immunoglobulin 
IL interleukin 
kDa kilo Dalton 
LAL Limulus amebocyte lysate 
LPS lipopolysaccharide 
LRR leucine-rich repeats 
M (nM, mM) mol (nanomol, millimol) 
MDP muramyl dipeptide 
MHC major histocompatibility complex 
min minute 
ml millilitre 
mRNA messenger RNA 
Neg. negative 
NK-cell natural killer cell 
NLR NOD-like receptor 
nm nanometer 
PAMP pathogen-associated molecular pattern 
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PBMC peripheral blood mononuclear cells 
PBS phosphate buffered saline 
PCR (RT-PCR, qPCR) polymerase chain reaction 
Pol. polymerase 
Pos. positive 
PRR pattern recognition receptor 
qPCR quantitative (real-time) PCR 
RNA ribonucleic acid 
rpm revolutions per minute 
RT room temperature 
RT-PCR reverse transcriptase PCR 
SD standard deviation 
sec second 
SLIT sublingual immunotherapy 
Ta annealing temperature 
TGF transforming growth factor 
Th helper T-cell 
TIR Toll/Interleukin-1 receptor 
TLR Toll-like receptor 
Tm melting temperature 
TNF tumour necrosis factor 
UV ultra violet 
w/o without 
w/v weight per volume 
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2. Abstract 
 
Sublingual immunotherapy (SLIT) is a safe and effective option for treatment of type I 
allergy. Still, the immune mechanisms underlying SLIT are not completely understood. In this 
context, the aim of the master thesis was to analyse the expression of toll-like receptor (TLR) 
1-10, C-type lectin receptor DC-SIGN, Dectin-1 and Dectin-2 and NOD-like receptor NOD1 
and NOD2 by human epithelial cells. For this purpose, a buccal mucosa cell line, HO-1-N-1, 
a sublingual epithelial cell line, HO-1-u-1, and two intestinal Caco-2 cell lines were 
employed. mRNA expression of the different receptors was analysed by reverse-transcription 
PCR (RT-PCR) and quantitative real-time RT-PCR (qPCR). Moreover, all epithelial cell lines 
were stimulated with ligands specific for the respective receptors. IL-8 secretion as a readout 
for the activation of their signalling pathways was determined by ELISA. 
HO-1-N-1 cells expressed mRNA for TLR1, TLR2, TLR4, TLR6 as well as NOD1 and 
NOD2 and responded with increased IL-8 synthesis to ligands specific for these receptors. 
qPCR also indicated the expression of TLR3, TLR8, TLR10 and Dectin-1 in HO-1-N-1. 
However, the cells were not activated by ligands specific for these receptors.  
Analysing the HO-1-u-1 cell line, mRNA coding for TLR1, TLR3, TLR4, TLR5, TLR6 and 
NOD1 was detected. qPCR also indicated expression of TLR2, TLR7, TLR8, TLR10 and 
Dectin-1. However, HO-1-u-1 cells only responded to ligands targeting TLR3, TLR5 and 
NOD1.  
In addition to the epithelial cell lines in the mouth, all experiments were performed with the 
well-established colorectal epithelial cell lines Caco-2/15 and Caco-2 A9. These cells 
expressed mRNA for all 10 currently known human TLRs as well as for NOD1. Additionally, 
mRNA coding for Dectin-2 was detected in Caco-2/15 by qPCR. Analysing the functional 
response, Caco-2 cells showed IL-8 production upon stimulation with ligands for TLR1/2, 
TLR2/6 and for TLR5. 
In conclusion, we found that sublingual and buccal cells show differences in the expression of 
pattern recognition receptors and respond to stimulation with microbial ligands in a tissue-
specific fashion. The spectrum of ligands activating the buccal cell line HO-1-N-1 indicates 
that these cells are basically specialised in recognising bacterial compounds. The sublingual 
epithelial cell line HO-1-u-1 responded to fewer ligands but within a broader spectrum, 
comprising viral dsRNA, bacterial flagellin and peptidoglycan. 
- 8 - 
3. Introduction 
3.1. The immune system 
The human immune system can be divided into the innate or native immunity and the 
adaptive or specific immunity. 
Innate immunity represents the phylogenetically oldest mechanism of the immune system. It 
provides the first line of defence against microorganisms in order to prevent or eliminate 
infections of the host, or to stimulate adaptive immune responses. In this context, the 
epithelial tissue plays an important role as a physical barrier against microbial invasion. 
This epithelial barrier consists of cells arranged in continuous layers that cover the body 
surface or line the body cavity or the lumen of internal organs. They are tightly connected by 
numerous intercellular junctions. The apical surface of an epithelial cell faces the body 
surface and may contain cilia and microvilli. The lateral surface faces the adjacent cells on 
either side, and the basal surface adheres to deeper cell layers or extracellular materials. 
The epithelial tissue can be classified into unilaminar epithelium consisting of a single cell 
layer, stratified epithelium consisting of multiple cell layers, and pseudostratified epithelium, 
which appears to be multilaminar because not all the cells reach the surface. Furthermore, 
epithelial cells are classified according to their shape, into squamous, cuboidal and columnar 
cells, and transitional cells that change their shape. 
Epithelial cells have their own nerve supply, but are avascular, and therefore, receive their 
nutrition by diffusion from neighbouring connective tissue. A high division rate allows the 
epithelium to constantly renew itself (Standring et al., 2005; Tortora and Derrickson, 2009). 
Epithelia function as selective barriers that facilitate or limit the transfer of substances and 
protect underlying tissues against dehydration and damage. Additionally, as mentioned 
before, epithelial cells play an important role in the regulation of immune responses, host 
defence and inflammation (Schleimer et al., 2007). 
Further mechanisms of the innate immune system include phagocytic cells like macrophages 
and natural killer (NK) cells, the complement system and the production of cytokines (Abbas 
et al., 2007). 
Although innate immune responses cannot adapt to particular pathogens during infections, it 
has been shown that innate immunity is far more specific than previously assumed (Le 
Bourhis et al., 2007; Akira et al., 2006). Thereby, the innate immune system relies on the 
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recognition of several structures conserved among microorganisms, known as pathogen-
associated molecular patterns (PAMPs), by pattern recognition receptors (PRR) (Takeuchi 
and Akira, 2010).  
Cell-associated PRRs of the innate immune system are located on the surface or in 
intracellular compartments of various cells, including macrophages, dendritic cells (DC) and 
epithelial cells. PRR recognise microbial components, which are essential for the survival of 
the microorganism, as these targets cannot be altered or discarded that easily. Moreover, they 
detect stressed or injured host cells by danger-associated molecular patterns (DAMPs). PRRs 
are encoded in the germline DNA of the cell, and are constitutively expressed in order to 
detect pathogens autonomously of the cell’s life-cycle stage. In contrast to the mechanisms of 
the adaptive immunity, PRRs are nonclonal and do not produce immunological memory 
(Akira et al., 2006; Abbas et al., 2007). 
Several classes of PRRs of the innate immune system have been identified so far, including 
Toll-like receptors (TLR), C-type lectin receptors (CLR), and NOD-like receptors (NLR).  
Each PRR is specific for particular PAMPs. After recognising their ligand, most PRRs 
upregulate the transcription of genes encoding proinflammatory cytokines, type I interferons, 
chemokines and other genes involved in inflammatory responses (Takeuchi and Akira, 2010). 
 
The adaptive or specific immunity can be divided into the humoral immune response 
mediated by antibody-producing B lymphocytes and the cellular immune response mediated 
by T lymphocytes. 
B lymphocytes recognise intact microbes or microbial antigens in their native form and 
differentiate into antibody-secreting plasma cells. The antibodies circulate in the blood and 
are important for the neutralization of antigens, opsonisation, activation of the complement 
system, targeting for phagocytosis and the activation of mast cells. 
Antibodies/immunoglobulins (Ig) are classified into 5 subtypes, namely IgM, IgD, IgG, IgA 
and IgE. 
T lymphocytes recognise microbial peptides displayed by antigen presenting cells (APC) in 
combination with a MHC (major histocompatibiliy complex) molecule. Moreover, the T cell 
needs co-stimulators (f.e. CD80, CD86) for activation. Activated CD8+ cytotoxic T 
lymphocytes kill infected cells. Activated CD4+ helper T lymphocytes differentiate into 
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effector cells and secrete cytokines that stimulate different cells of the immune system. Helper 
T cells can be divided into Th1, Th2 and Th17 cells (Abbas et al., 2007). 
 
3.2. Pattern recognition receptors (PRR) of the innate immune system 
3.2.1. Toll-like receptors (TLRs) 
TLRs were first described in 1994 by Nomura and coworkers, and are named after the Toll 
protein in Drosophila (Abbas et al., 2007). They are membrane-bound receptors, namely type 
I integral membrane glycoproteins, recognising pathogens outside the cell and in intracellular 
compartments. 
TLRs consist of various leucine-rich repeats (LRRs) on the N-terminus, a transmembrane 
region, and a cytoplamic Toll/IL-1 receptor (TIR) homology domain (Takeuchi and Akira, 
2010). 
Currently, ten different TLRs have been identified in humans (see Table 1), mainly on 
immune cells such as macrophages, DCs, B- and T-cells, and non-immune cells including 
fibroblasts and epithelial cells (Akira et al., 2006). However, it is reported that surface 
epithelial cells of the gastrointestinal tract either lack expression of TLRs or their co-
receptors, or express TLRs at rather low levels (Athman and Philpott, 2004). 
Table 1: TLRs and their ligands - adapted from “PRRs and their Ligands” (Takeuchi and Akira, 2010). 
TLR Localization Ligand Origin of the Ligand 
TLR1 Plasma membrane Triacyl lipoprotein Bacteria 
TLR2 Plasma membrane Lipoprotein Bacteria, viruses, parasites, 
fungi, self 
TLR3 Endolysosome dsRNA Virus 
TLR4 Plasma membrane LPS Bacteria, viruses, fungi, self 
TLR5 Plasma membrane Flagellin Bacteria 
TLR6 Plasma membrane Diacyl lipoprotein Bacteria, viruses 
TLR7, TLR8 Endolysosome ssRNA Virus, bacteria, self 
TLR9 Endolysosome CpG-DNA Virus, bacteria, protozoa, self 
TLR10 Endolysosome unknown unknown 
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TLR 1, 2, 4, 5 and 6 are expressed on the cell surface, whereas TLR 3, 7, 8, 9 and 10 are 
expressed in intracellular compartments such as endosomes. The localization of the TLRs is 
essential, as they are not able to distinguish between self and non-self, nor between 
pathogenic and commensal microorganisms (Medzhitov and Janeway, 2002). 
Each TLR recognises different PAMPs including lipids, nucleic acids and proteins. TLR1, 
TLR2 and TLR6 sense certain lipoproteins. TLR3 recognises viral double stranded RNA and 
its synthetic analogue polyinosinic-polycytidylic acid [Poly(I:C)] (Alexopoulou et al., 2001). 
TLR4 senses lipopolysaccharides in Gram-negative bacteria, but is also involved in the 
recognition of viruses by binding to viral envelope proteins. TLR5 binds bacterial flagellin. 
TLR7 and TLR8 bind single stranded RNA, and TLR9 recognizes unmethylated 
deoxycytidylate-phosphate-deoxyguanylate (CpG) motifs within bacterial DNA (Takeuchi 
and Akira, 2010). 
When TLRs recognise a certain PAMP, they become activated by dimerisation and recruit 
certain TIR domain-containing adaptor molecules such as myeloid differentiation factor 88 
(MyD88), the TIR-domain-containing adaptor inducing IFN-beta (TRIF/TICAM-1), TIR-
containing adaptor protein (TIRAP/Mal) or TRIF-related adaptor molecule (TRAM). The 
activation of protein kinases by these adaptors results in the triggering of downstream 
signalling cascades, which lead to transcriptional upregulation of genes coding for 
inflammatory cytokines (e.g. TNF, IL-1 and IL-12), chemokines (e.g. IL-8, MCP-1 and 
RANTES), endothelial adhesion molecules and other relevant genes of the innate immune 
system. Thereby, MyD88 is essential for downstream signalling of all TLRs except TLR3, 
which triggers TRIF-dependent signalling. TLR4 recruits both MyD88 and TRIF, but requires 
TRAM for TRIF activation (Takeuchi and Akira, 2010; Abbas et al., 2007; Akira et al., 
2006). 
 
3.2.2. C-type lectin receptors (CLRs) 
C-type lectins are a superfamily of proteins that recognise carbohydrates, mostly on 
microorganisms, in a calcium-dependent manner (Weis et al., 1998), and stimulate the 
production of proinflammatory cytokines and other molecules. Moreover, they generate 
signals that inhibit TLR-mediated immune complexes (Takeuchi and Akira, 2010). CLRs are 
expressed on the plasma membrane of various cells including macrophages and DCs (Abbas 
et al., 2007). They are divided into type I and type II receptors according to their carbonate 
recognition domains (CRD). 
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Dendritic cell-associated C-type lectin 1 (Dectin-1) is a type II receptor with only a single 
CRD. It is expressed by DCs but also by macrophages, monocytes, neutrophils and other cell 
types. Dectin-1 binds β-glucans present in the cell walls of fungi and some bacteria (Hollmig 
et al., 2009), f.e. β-1,3-glucan (Curdlan), and is able to induce immunity through a Syk and 
CARD9-dependent pathway (Robinson et al., 2009). 
Dendritic cell-associated C-type lectin 2 (Dectin-2) is another member of the type II receptor 
family. However, the amino acid sequence of Dectin-2 is only 22 % homologous to Dectin-1 
(Hollmig et al., 2009). Dectin-2 seems more restricted to DCs than Dectin-1, but is also 
expressed on macrophages and inflammatory monocytes. It has been shown to bind high-
mannose carbohydrates; nevertheless, the PAMPs recognized by Dectin-2 have not yet been 
fully identified. It seems that Dectin-2 not only recognizes fungal PAMPs, as the receptor 
might play a role in house dust mite allergy (Robinson et al., 2009). 
Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), 
also known as CD209, is basically expressed on DCs. It has high affinity for intercellular 
adhesion molecule-3 (ICAM-3) and binds high-mannose glycoproteins like mannan. Thereby, 
DC-SIGN recognises a variety of microorganisms including certain viruses, bacteria and 
fungi (Svajger et al., 2010). 
 
3.2.3. NOD-like receptors (NLRs) 
Nucleotide-binding oligomerization domain (NOD)-like receptors are a family of 
cytoplasmatic molecules that recognise bacterial products within the intracellular 
compartment (Girardin et al., 2003a). NOD1/CARD4 and NOD2/CARD15 are two members 
of this pattern recognition family, which recognise substructures of bacterial peptidoglycan 
(Le Bourhis et al., 2007). 
NOD1 detects meso-diaminopimelic acid (DAP)-containing peptidoglycan, which is common 
in Gram-negative bacteria and particular Gram-positive bacteria such as Bacillus subtilis and 
Listeria monocytogenes. NOD1 is known to be expressed by spleen cells, macrophages and a 
variety of epithelial cells (Chamaillard et al., 2003). 
NOD2 senses muramyl dipeptide (MDP, MurNAc-L-Ala-D-isoGln), which is found in both 
Gram-negative and Gram-positive bacteria. However, NOD2 expression seems to be more 
restricted to certain cell types than NOD1 (Girardin et al., 2003b; Le Bourhis et al., 2007). 
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Mutations in NOD2 are thought to increase the susceptibility of Crohn’s disease, an 
inflammatory disease of the intestine (Athman and Philpott, 2004). 
 
3.3. Human epithelial cell lines 
HO-1-N-1 (Nakata-1; JCRB0831) is a squamous carcinoma cell line isolated from the human 
buccal mucosa. Although the cell line was established by Moroyama and coworkers in 1986, 
HO-1-N-1 cells are scarcely characterised with regard to their expression of PRRs. 
HO-1-u-1 (Ueda-1; JCRB0828) is a squamous carcinoma cell line isolated from the 
sublingual mucosa of a 72-year old Japanese male. The cell line was established by Miyauchi 
and coworkers in 1985. They observed a population doubling time of approximately 23 hours, 
the hyperdupoidy of the cell’s karyotype and the formation of epithelial-like cell layers when 
grown on cell culture flasks. 
In 2007, Uehara and colleagues postulated that HO-1-u-1 expressed the mRNA of TLR2, 
TLR3, TLR4, TLR7, NOD1 and NOD2, but did not secrete proinflammatory cytokines such 
as IL-8 in response to bacterial PAMPs. 
Moreover, Wang and co-workers (2006, 2008) evaluated HO-1-u-1 cells grown on cell 
culture inserts as an in vitro model for studying sublingual drug delivery by passive diffusion. 
Caco-2/15 and Caco-2 A9 are two heterogeneous human epithelial colorectal adenocarcinoma 
cell lines. Grown on cell culture inserts, Caco-2 cells are well established as in vitro model of 
the human intestinal mucosa (Sambuy et al., 2005). 
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4. Aims of the thesis 
The aim of the master thesis was to characterise the expression of PRRs on human oral 
epithelial cells. For this purpose, we have investigated the expression of TLR 1-10, NLR 
NOD1 and NOD2, and CLR DC-SIGN, Dectin-1 and Dectin-2 by buccal and sublingual 
epithelial cell lines. 
The presence of PRR mRNA was analysed by reverse-transcription polymerase chain reaction 
(RT-PCR) and quantitative real-time RT-PCR (qPCR). Moreover, epithelial cell lines were 
stimulated with ligands specific for the respective receptors. IL-8 secretion as a readout for 
the activation of their signalling pathway was determined by ELISA. 
In addition to oral epithelial cell lines, all experiments were performed with the well-
established colorectal epithelial Caco-2 cell line. 
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5. Materials and Methods 
5.1. Tissue culture 
The HO-1-u-1 cell line derived from a sublingual squamous cell carcinoma and the HO-1-N-1 
cell line derived from a buccal mucosa squamous cell carcinoma (Table 2) were purchased 
from the Health Science Research Resources Bank (Osaka, Japan). 
 
Table 2: Characteristics of the cell lines HO-1-N-1 and HO-1-u-1. 
Cell name HO-1-N-1 HO-1-u-1 
Cell number JCRB0831 JCRB0828 
Lot number 04092001 10172000 
Source (genus/species) Homo sapiens Homo sapiens (72-year old male) 
Tissue Buccal mucosa Sublingual mucosa 
Case history Squamous cell carcinoma Squamous cell carcinoma 
Life span Infinite Infinite 
Morphology Epithelial-like Epithelial-like 
 
5.1.1. Culturing of the cells 
HO-1-N-1 and HO-1-u-1 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
- Nutrient Mixture F-12 (Ham) + GlutaMAXTM (GIBCO Invitrogen) supplemented with 10 % 
of fetal calf serum (FCS; PAA). 
Caco-2/15 and Caco-2 A9 cells were cultured in DMEM high glucose (PAA) supplemented 
with 10 % of FCS and additional glutathione. 
All cells were cultured at 37˚C in a humidified atmosphere with 5% CO2. 
 
5.1.2. Isolation of peripheral blood mononuclear cells (PBMC) 
15 ml of Ficoll solution were overlaid with approximately 35 ml of heparinised blood, which 
had been diluted 1:2 with DPBS (GIBCO, Invitrogen), and centrifuged for 30 min at 1310 
rpm (22°C, stop without brake). Then, the PBMC-containing interphase was transferred into a 
new tube, and DPBS was added to a volume of 50 ml. After centrifuging for 10 min at 1950 
rpm (22°C, maximal brake), the pellet was vortexed, resuspended in 5 ml of DPBS, filled up 
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to 50 ml with DPBS and centrifuged for 8 min at 1780 rpm (22°C, maximal brake). The pellet 
was again vortexed, resuspended in 5 ml of DPBS and filled up to 50 ml with DPBS. 
 
5.1.3. Separation of dendritic cells (DC) 
DCs were separated from PBMCs using CD14 MicroBeads (MACS Miltenyi Biotec). The 
separation was performed according to the manufacturer’s protocol. 
 
 
5.2. Isolation of mRNA and transcription into cDNA 
5.2.1. RNA isolation 
Quiagen RNeasy kit, performed according to the manufacturer’s instructions. 
The cells were harvested by trypsinisation and centrifugation for 5 min at 300x g. 
350 or 600 µl of RTL buffer containing ß-mercaptoethanol (depending on the amount of cells 
used for the isolation) were added to the harvested cells, and the lysate was homogenised 
using a QIAshredder spin column or a syringe. 
Then, one volume (350 or 600 µl) of ethanol (70 %) was added to the sample, and up to 700 
µl were pipetted on an RNeasy spin column which was spinned for 15 sec before discarding 
the flow-through. The column was washed with 700 µl of RW1 buffer and twice with 500 µl 
of RPE buffer (2 min centrifugation step after the second wash). In the end, the column was 
placed into a new 1.5 ml tube and the mRNA was finally eluted by adding 30 µl nuclease-free 
dH2O directly on the membrane followed by a 1 min centrifugation step (max. speed). All 
pipetting steps were performed using filtered tips. 
The final concentration of isolated RNA was measured at a wavelength of 260 nm on 
Nanodrop. 
5.2.2. cDNA transcription 
Applied Biosystems High-capacity cDNA reverse transcription kit, performed according to 
the manufacturer’s instructions. 
The assay was carried out in volumes of 20 µl, each reaction containing the reagents given in 
table 3. 
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Table 3: Reagents for cDNA transcription. 
Reagent Amount per reaction 
dH2O (nuclease-free) 3.2 µl 
RNase inhibitor 1 µl 
RT random primers (10x) 2 µl 
dNTP mix 0.8 µl 
RT buffer (10x) 2 µl 
Reverse transcriptase 1 µl 
Isolated RNA 10 µl 
 
The cDNA transcription was performed in a thermocycler (Peqlab 96 Universal Gradient) 
using the following conditions: 
25°C, 10 min 
37°C, 120 min 
85°C, 5 sec 
4°C, indefinitely 
 
Finally, the cDNA was stored at -20°C for further usage. 
 
 
5.3. Reverse transcription polymerase chain reaction (RT-PCR) 
 
Polymerase chain reaction (PCR) was developed in 1983 by Kary Mullis, and is a sensitive 
method for amplification and detection of small amounts of a specific target DNA. 
Apart from the DNA of interest, specific oligonucleotide primers, deoxynucleotide 
triphosphates (dNTPs), a reaction buffer optimized for magnesium chloride and a 
thermostable DNA polymerase are needed in order to perform PCR. 
In a denaturation phase, the template DNA separates into single strands and in the annealing 
phase, the primers anneal to the specific target sequence. During the elongation phase, the 
DNA polymerase extends the primers by incorporating dNTPs and thereby amplifies the 
target DNA.  
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The amount of target DNA increases exponentially in the earlier amplification cycles, but 
reaches a plateau phase in the later cycles because of the decrease in reaction components. For 
this reason, RT-PCR is called a semi-quantitative method (Theophilus, 2008). 
 
Primers specific for the different genes of interest (Table 4) were designed by Dr. Claudia 
Kitzmüller using the primer-BLAST program (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/) and were purchased from Sigma Aldrich. 
 
Table 4: RT-PCR primer. 
Gene* Primer seqence Length of PCR product 
TLR1a 
TLR1b 
CAC TGA GAG TCT GCA CAT TGT 
GTG TCT CCA ACT CAG TAA GGT 566 bp 
TLR2a 
TLR2b 
TTT ATC GTC TTC CTG CTT CAA GCC C 
TCT CGC AGT TCC AAA CAT TCC ACG 350 bp 
TLR3a 
TLR3b 
GCA AAC CAC AAG CAT TCG GAA TCT G 
TTG AAG GCT TGG GAC CAA GGC A 713 bp 
TLR4a 
TLR4b 
TTT CTG CAA TGG ATC AAG GAC CAG 
GGA CAC CAC AAC AAT CAC CTT TCG G 440 bp 
TLR5a 
TLR5b 
CAG TGA CCA AAA CAG ATT CAA CC 
AAG AAA CCA GCC AAC ATC CTG 331 bp 
TLR6a  
TLR6b 
TCA CCA GAG GTC CAA CCT TAC 
CAA GTT GTT GCA AAG CTT CCA G 700 bp 
TLR7a 
TLR7b 
TCT ACC TGG GCC AAA ACT GTT 
GGC ACA TGC TGA AGA GAG TTA 388 bp 
TLR8a 
TLR8b 
CCG ACT TGG AAG TTC TAG ATC 
AAT GCT TCA TTT GGG ATG TGC T 316 bp 
TLR9a 
TLR9b 
CTT CCT CTA CAA ATG CAT CAC T 
GTG ACA GAT CCA AGG TGA AGT 488 bp 
DC-SIGNa 
DC-SIGNb 
CTC CCA GCG GAA CTG GCA CG 
GTT TGG GGT GGC AGG GGC TG 385 bp 
Dectin-1a 
Dectin-1b 
AGG TGC CAG CCT GGG GAT GT 
CCA GCC CCA TCC TGT AGG TTT CCA 311 bp 
Dectin-2a 
Dectin-2b 
AGG TGC CAG CCT GGG GAT GT 
CCA GCC CCA TCC TGT AGG TTT CCA 353 bp 
NOD1a 
NOD1b 
CAG CCT GTG CTC TGT GCC CC 
CCC TGC AGG CAC TGG AAC GG 555 bp 
NOD2a 
NOD2b 
CCT GTG CCC GCT GGT GTC TG 
CCA AGG CTT CAG CCA GGG CC 657 bp 
* a: forward primer, b: reverse primer 
 
All reagents were kept on ice. With the intention to avoid contamination, filtered tips were 
used and gloves were changed frequently. The PCR assay was carried out in volumes of 20 
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µl, each reaction containing the reagents given in table 5. To simplify the pipetting process, 
master mixtures were prepared. 
Table 5: Reagents for RT-PCR. 
Reagent Concentration Amount per reaction Company 
dH2O (nuclease-free) - 14.3 µl - 
dNTPs 10 mM 0.5 µl Fermentas 
PCR buffer 10x 2 µl  Finnzymes 
forward primer 5 µM 1 µl Sigma 
reverse primer 5 µM 1 µl Sigma 
cDNA* - 1 µl - 
Dynazyme pol. - 0.2 µl Finnzymes 
* replaced by nuclease-free dH2O in neg. controls 
 
5.3.1. Evaluation of optimal PCR conditions for the primer pairs of TLR 1-9 
As a rule of thumb, annealing temperature is expected to be 5-10°C below the lower Tm° of 
the primer pair. The Peqlab 96 Universal Gradient thermocycler is able to establish a 
temperature gradient, which results in a different temperature for each of the 12 rows (8 
samples each) of the cycler. In this experiment, a gradient of 57°C +/- 10°C was used in order 
to achieve appropriate annealing temperatures for each PCR sample (Table 6). 
 
Table 6: Evaluation of the optimal annealing temperature. 
TLR 
Tm° 
primer a 
Tm° 
primer b 
annealing temp. – 
optimal range 
annealing temperatures tested  
TLR1 60.6°C 57.3°C 47.3 - 52.3°C 47.0°C, 48.0°C, 49.5°C, 51.4°C 
TLR2 70.6°C 72.8°C 60.6 - 65.6°C 60.1°C, 62.3°C, 64.3°C, 65.7°C 
TLR3 72.8°C 73.6°C 62.8 - 67.8°C 62.3°C, 64.3°C, 65.7°C, 66.6°C 
TLR4 70.0°C 72.8°C 60.0 - 65.0°C 60.1°C, 62.3°C, 64.3°C, 65.7°C 
TLR5 64.4°C 65.1°C 54.4 - 59.4°C 55.8°C, 58.0°C, 60.1°C, 62.3°C 
TLR6 62.9°C 65.8°C 52.9 - 57.9°C 53.6°C, 55.8°C, 58.0°C, 60.1°C 
TLR7 64.5°C 62.0°C 52.0 - 57.0°C 51.4°C, 53.6°C, 55.8°C, 58.0°C 
TLR8 59.4°C 66.5°C 49.4 - 54.4°C 48.0°C, 49.5°C, 51.4°C, 53.6°C 
TLR9 59.8°C 60.6°C 49.8 - 54.8°C 48.0°C, 49.5°C, 51.4°C, 53.6°C 
 
Expecting the Dynazyme polymerase to synthesize 2000 nucleotides per minute, an 
elongation time of 1 min was chosen. 
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- Sample: PBMC cDNA (diluted 1:5 in nuclease-free dH2O) 
- Negative control: nuclease-free dH2O 
 
PCR was performed in a thermocycler (Peqlab 96 Universal Gradient) using the following 
conditions: 
95°C, 5 min 
35 cycles: 
Denaturation: 95°C, 30 sec 
Annealing: gradient (57°C +/- 10°C) - individual annealing temperature for each primer 
pair (see table above), 40 sec 
Elongation: 72°C, 1 min 
72°C, 8 min 
4°C, indefinitely 
 
5.3.2. PCR screening of epithelial cell lines for TLR 1-9 
- Samples: cDNA derived from the epithelial cell lines (diluted 1:5) 
- Positive control: PBMC cDNA (diluted 1:5) 
- Negative control: nuclease-free dH2O 
 
Amplification was performed in a thermocycler (Peqlab 96 Universal Gradient) using 
different cycle numbers: 
95°C, 5 min 
35, 30, 28 or 25 cycles: 
Denaturation: 95°C, 30 sec 
Annealing: gradient (57°C +/- 10°C) - individual annealing temperature for each primer 
pair (see table 7), 40 sec 
Elongation: 72°C, 1 min 
72°C, 8 min 
4°C, indefinitely 
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Table 7: Individual annealing temperatures for each primer pair (see Results). 
Primer pair Ta° Primer pair Ta° Primer pair Ta° 
TLR1 51.4°C TLR4 64.3°C TLR7 55.8°C 
TLR2 62.3°C TLR5 58.0°C TLR8 48.0°C 
TLR3 65.7°C TLR6 60.1°C TLR9 49.5°C 
 
5.3.3. PCR screening of epithelial cell lines for DC SIGN, Dectin-1, Dectin-2, 
NOD1 and NOD2 
- Samples: cDNA derived from the epithelial cell lines (diluted 1:5) 
- Positive control: cDNA from PBMCs and DCs 
- Negative control: nuclease-free dH2O 
 
PCR was performed in a thermocycler (Peqlab 96 Universal Gradient) using the following 
conditions: 
95°C, 5 min 
30 cycles: 
Denaturation: 95°C, 30 sec 
Annealing: 60°C, 40 sec 
Elongation: 72°C, 1 min 
72°C, 8 min 
4°C, indefinitely 
 
5.3.4. Evaluation of cDNA concentration by β-actin amplification 
Human β-actin is a so-called house-keeping gene, and therefore, suitable for comparing the 
concentration of the different cDNA samples used in PCR screenings. 
 
- Samples: cDNA, diluted 1:5 with nuclease-free dH2O. 
- Negative control: nuclease-free dH2O 
 
All reagents were kept on ice. With the intention to avoid contamination, filtered tips were 
used and gloves were changed frequently. The PCR assay was carried out in volumes of 20 
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µl, each reaction containing the reagents given in table 8. To simplify the pipetting process, 
master mixtures were prepared. 
 
Table 8: Reagents for β-actin amplification. 
Reagent Concentration Amount per reaction Company 
dH2O (nuclease-free) - 14.3 µl - 
dNTPs 10 mM 0.5 µl Fermentas 
PCR buffer 10x 2 µl  Finnzymes 
ß-actin forward primer 5 µM 1 µl Sigma Aldrich 
ß-actin reverse primer 5 µM 1 µl Sigma Aldrich 
cDNA (1:5) * - 1 µl - 
Dynazyme pol. - 0.2 µl Finnzymes 
* replaced by nuclease-free dH2O in neg. controls 
 
β-actin amplification was performed in a thermocycler (Peqlab 96 Universal Gradient) using 
the following conditions: 
95°C, 1 min 
94°C, 3 min 
25 cycles: 
Denaturation: 95°C, 30 sec 
Annealing: 55°C, 35 sec 
Elongation: 72°C, 45 sec 
72°C, 7 min 
4°C, indefinitely 
 
5.3.5. DNA gel electrophoresis 
PCR products were analysed by DNA gel electrophoresis. 
For a 1 % (w/v) gel, 1 g of agarose was added to 100 g of 1 x TBE buffer, and the mixture 
was heated in the microwave oven in order to solve the agarose. After cooling to 
approximately 40°C, 2 drops (60 µl) of a 0.07 % (w/v) ethidium bromide solution were 
added, and the gel was poured in a BioRad electrophoresis tray (BioRad Laboratories 
Ges.m.b.H.) with two 20-well combs. When the gel has finally polymerised, the combs were 
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removed and the gel was transferred to the electrophoresis chamber (BioRad Sub-Cell GT 
Agarose Gel Electrophoresis Systems), filled with 1 x TBE as a running buffer. 
Before loading, 3 µl of a 6x DNA loading dye (Fermentas) were added to 15 µl of the 
samples. Subsequently, 18 µl of each sample and, additionally, 12-18 µl of DNA ladder (e.g.  
GeneRulerTM 100 bp or FastRulerTM middle range DNA ladder, Fermentas) were loaded on 
the gel, and electrophoresis was performed for 40 min at 90 volt. 
Finally, DNA bands were visualized under UV-light. 
 
5.4. Quantitative Real-time PCR (qPCR) 
 
In real-time PCR, relative quantification of PRR mRNA was performed by measuring 
increasing fluorescence signals that results from SYBR green binding to double stranded 
DNA during amplification. The cycle number at which the detected fluorescence reaches a 
fixed threshold within the exponential phase of the DNA amplification is called threshold 
cycle number (Ct). 
10x QuantiTect Primer Assays for the following PRRs were purchased from Quiagen (Table 
9). 
 
- Samples: cDNA derived from the epithelial cell lines 
- qPCR controls: PBMC cDNA, DC cDNA 
- Negative control: nuclease-free dH2O 
 
Table 9: QuantiTect primer assays. 
Assay name Gene symbol Cat. No. Lot no. 
Hs_TLR1_3_SG TLR1 QT01667218 98207961 
Hs_TLR2_1_SG TLR2 QT00236131 98207163 
Hs_TLR3_1_SG TLR3 QT00007714 98207962 
Hs_TLR4_2_SG TLR4 QT01670123 98207164 
Hs_TLR5_3_SG TLR5 QT01682079 98207265 
Hs_TLR6_1_SG TLR6 QT00216272 98207963 
Hs_TLR7_1_SG TLR7 QT00030030 98207266 
Hs_TLR8_2_SG TLR8 QT01666420 98207267 
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Hs_TLR9_1_SG TLR9 QT00015183 98207268 
Hs_TLR10_1_SG TLR10 QT00205478 98207269 
Hs_CD209_2_SG CD209 (DC-SIGN) QT01665447 98207271 
Hs_CLEC7A_1_SG CLEC7A (Dectin-1) QT00024059 98207964 
Hs_CLEC6A_2_SG CLEC6A (Dectin-2) QT01342292 98239840 
Hs_NOD1_1_SG NOD1 QT00054082 98207965 
Hs_NOD2_1_SG NOD2 QT00025872 98207270 
The lyophilised primers were solved in TE-buffer (pH 8; Ambion) according to the 
manufacturer’s instructions and stored at -20°C. 
 
All reagents were kept on ice and, in order to avoid contamination, filtered tips were used. 
The PCR assay was carried out in volumes of 20 µl in a 96-well PCR plate. To simplify the 
pipetting process, master mixtures were prepared (see table 10). The amplifications were 
performed in triplicates, and a negative control without a template was included in each run. 
 
Table 10: Reagents for qPCR. 
Reagent Conc. Amount/reaction Company 
Power SYBR Green PCR Master Mix 2 x 10 µl Applied Biosystems 
QuantiTect Primer Assay 10 x 2 µl Quiagen 
cDNA template* 5 ng/µl 2 µl  - 
Nuclease-free dH2O - 6 µl - 
* replaced by nuclease-free dH2O in neg. controls 
 
 
Additionally, the house keeping gene EF1 in human was amplified as an internal control gene 
(see table 11). Similar to β-actin, human EF1 is expressed at constant levels in all cell lines 
tested. The purpose of this internal standard is to normalise the PCR for the amount of DNA 
used in the reaction (Livak and Schmittgen, 2001). 
 
Table 11: Reagents for EF1 amplification. 
Reagent Conc. Amount/reaction Company 
Power SYBR Green PCR Master Mix 2 x 10 µl Applied Biosystems 
hEF1 Primer (forward) 500 nM 2 µl Sigma Aldrich 
hEF1 Primer (reverse) 500 nM 2 µl Sigma Aldrich 
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cDNA template* 5 ng/µl 2 µl  - 
Nuclease-free dH2O - 4 µl - 
* replaced by nuclease-free dH2O in neg. controls 
 
In the end, the wells of the 96-well PCR plate were sealed with a plastic foil, and the plate 
was centrifuged for 2 min at 1800 rpm to eliminate air bubbles. 
 
Quantitative real-time PCR was performed with an ABI 7900 HT Fast Real-Time PCR 
System (Applied Biosystems) using the SDS 2.3 software. 
Assay: Standard curve, 96-well plate, blank template 
Thermal cycling parameters: 
Step 1: 50°C, 2 min 
Step 2 – enzyme activation: 95°C, 10 min 
Step 3 – amplification (40 cycles): 95°C, 15 sec; 60°C, 1 min 
Step 4 – dissociation curve: 95°C, 15 sec; 60°C, 15 sec 
 
Data analysis of qPCR was performed using the SDS 2.3 software and Microsoft Office 
Excel. 
The cycle number at which the detected fluorescence reaches a fixed threshold was 
determined from an exponential plot of the fluorescence vs. cycle number. A threshold cycle 
number (Ct) above cycle 35 implies negative results. 
In order to compare the relative amounts of a DNA template in different cell lines, Ct values 
of the internal standard hEF1 was subtracted from Ct values of PRRs tested:  
Δ Ct = Ct PRR – Ct EF1 
Specificity of the PCR was confirmed by dissociation/melting curve analysis. Hereby, 
dissociation of the PCR products is expected to result in one peak at a specific melting 
temperature. Several smaller peaks at different temperatures indicate contaminations, 
mispriming or primer-dimer artefacts. 
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5.5. Limulus Amebocyte Lysate (LAL) - Assay 
PRR ligands used for stimulation of the cells were tested for bacterial endotoxin using QCL-
1000 Endpoint Chromogenic LAL-Assay (Lonza). Hereby, Gram-negative bacterial 
endotoxin catalyses activation of an enzyme in LAL, which releases p-nitroaniline from a 
chromogenic substrate. The experiment was performed according to the manufacturer’s 
instructions. 
5.5.1. Microplate-Method 
50 µl of the standards (E. coli Endotoxin: 1.0, 0.5, 0.25, 0.1 and 0.0 EU/ml) and samples were 
pipetted in the wells of a 96-well-plate at 37°C (heating block) in duplicates. At the time point 
T = 0 min, 50 µl of LAL were added to each well, and at T = 10 min, 100 µl of pre-warmed 
chromogenic substrate solution (2 mM) were added. Finally, the reaction was stopped at T = 
16 min by addition of 50 µl of 25 % v/v acetic acid per well, and absorbance was measured at 
405 nm at the Spectra Max Plus 384 plate reader (Molecular Devices) using SOFTmax Pro 
4.8 software. 
In order to determine the proper endotoxin concentration of the samples, endotoxin-free 
materials and water were used in the experiment, and all reagents were pipetted in the same 
order. 
 
5.6. Stimulation of epithelial cell lines with PRR ligands 
HO-1-N-1, HO-1-u-1 and Caco-2 cells (40 000 cells per well in 100 µl) were seeded in a 
flatbottomed 96-well plate (Corning B.V. Life Sciences) in their appropriate culture medium, 
and were incubated for 24 h at 37°C in a humidified atmosphere containing 5 % CO2. Then, 
medium was removed, and the cells were stimulated with three different concentrations of 
PRR ligands (Table 12) in a final volume of 100 µl in fresh medium. The assay was 
performed in triplicates, and cells in plain medium without any stimuli were used as negative 
control. 
Table 12: PRR ligands. 
PRR ligands (Source) Company PRR Conc. 1 Conc. 2 Conc. 3 
Pam3CSK4 (synthetic) InvivoGen 
TLR1, 
TLR2 
10 µg/ml 1 µg/ml 100 ng/ml 
Poly(I:C) (synthetic) InvivoGen TLR3 100 µg/ml 10 µg/ml 1 µg/ml 
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LPS (Escherichia coli) - TLR4 1 µg/ml 100 ng/ml 10 ng/ml 
Flagellin (Bacillus subtilis) InvivoGen TLR5 20 nM 2 nM 200 pM 
FSL-1 (Mycoplasma salivarium) InvivoGen 
TLR2, 
TLR6 
100 ng/ml 10 ng/ml 1 ng/ml 
R848 (synthetic) InvivoGen 
TLR7, 
TLR8 
1 µg/ml 100 ng/ml 10 ng/ml 
Unmethylated CpG DNA - TLR9 10 µM 1 µM 100 nM 
iE-DAP (synthetic) InvivoGen NOD1 100 µg/ml 10 µg/ml 1 µg/ml 
MDP (synthetic) InvivoGen NOD2 100 µg/ml 10 µg/ml 1 µg/ml 
Curdlan (Alcaligenes faecalis) Sigma Dectin-1 100 µg/ml 10 µg/ml 1 µg/ml 
Mannan (Saccharomyces 
cerevisiae) 
Sigma 
DC-
SIGN 
1 mg/ml 100 µg/ml 10 µg/ml 
The cells were incubated for another 24 h at 37°C/5 % CO2. Finally, supernatants were 
collected, and the level of IL-8 secretion was determined by cytokine ELISA. 
 
5.7. Thymidine incorporation 
Medium containing [3H]-thymidine was added to the stimulated cells after collecting 
supernatants for ELISA. After 12-18 h of incubation at 37°C/5 % CO2, the cells were 
harvested on a filter. The filter was dried in the microwave, and sealed in plastic foil after 
addition of 4 ml of scintillation fluid (Betaplate scint, Perkin Elmer). Finally, a beta-counter 
was used for measuring the radioactivity of incorporated [3H]-thymidine, being directly 
proportional to the number of living cells. 
 
5.8. Determination of IL-8 
A Nunc Maxisorp 96 well ELISA plate (Thermo Scientific Inc.) was coated with 100 µl of an 
anti-human IL-8 coating antibody (SIL-8, Lot IJ107699; Thermo Fisher Scientific), diluted to 
a concentration of 2 µg/ml in carbonate buffer (pH 9.6), and incubated overnight at room 
temperature (RT). 
On the next day, the coating-antibody solution was discarded, and unspecific binding sites 
were blocked with 150 µl/well of PBS containing 0.05 % Tween 20 and 4 % (w/v) of bovine 
serum albumin (PBS/T/BSA) for 1-2 h at RT.  
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Afterwards, the plate was washed three times with PBS/0.05 % Tween (PBS/T), and 50 µl of 
the collected supernatants (see “Stimulation of the epithelial cell lines with PRR ligands”) 
were transferred to the plate. Due to the high level of IL-8 secretion observed, supernatants of 
HO-1-N-1 cells were diluted 1:100 in PBS/T/BSA while supernatants of HO-1-u-1 cells were 
diluted 1:250 in PBS/T/BSA. Additionally, IL-8 was applied as a standard in several 
concentrations in the range of 500-0 pg/ml in PBS/T/BSA. 
After 1 h, the standards/samples were discarded, and adsorbed IL-8 was bound by a 
biotinylated anti-IL-8 antibody in a concentration of 0.2 µg/ml, diluted in PBS/T/BSA (1 h, 
RT). Then, the plate was washed three times with PBS/T, and Biotin was detected using 
horseradish peroxidise conjugated streptavidin in a dilution of 1:20.000.  
Finally, the plate was washed once more, and the wells were incubated with 100 µl of the 
chromogenic substrate 3,3’,5,5’-Tetramethylbenzidine (TMB; Chemicon International Inc) 
for 30 min in the dark. The colour reaction was stopped by addition of 0.18 M H2SO4 (100 
µl/well), and extinction was measured at a wavelength of 450 nm (reference wavelength: 630 
nm) at the Spectra Max Plus 384 plate reader (Molecular Devices) using SOFTmax Pro 4.8 
software. Detected IL-8 was quantified by means of extinction values measured for IL-8 
standards. 
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5.9. Buffers and solutions 
 
10 x phosphate buffered saline (PBS): 
80 g NaCl 
2 g KCl 
14.4 g Na2HPO4 
2.4 g KH2PO4  
Fill to 1000 ml with H2O bidest., pH 7.4 
 
10 x Tris/Borate/EDTA (TBE) buffer: 
54 g Tris 
27.5 g boric acid 
4.65 g Na4EDTA 
Fill to 1000 ml with H2O bidest. 
 
Carbonate buffer: 
37 mM Na2CO3 
63 mM NaHCO3 
Solve in H2O bidest. 
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6. Results 
6.1. Qualitative detection of PRR mRNA by RT-PCR 
In order to perform PCR experiments, mRNA was isolated from epithelial cell lines and 
transcribed into cDNA. Quality and quantity of the resulting cDNA was confirmed by 
amplification of β-actin. 
6.1.1. Evaluation of optimal PCR conditions for the primer pairs of TLR 1-9 
First, optimal annealing temperatures for the different primer pairs used in RT-PCR to detect 
TLR were evaluated.  For this purpose, cDNA isolated from PBMCs was used, as these cells 
express all TLRs. Each primer pair was tested at four different annealing temperatures (Ta) 
within the optimal temperature range of the primers. Resulting PCR products were visualised 
by gel electrophoresis using EtBr-staining. Bands resulting from unspecific amplification 
indicated that the Ta was too low. A reduced yield of the correct product indicated that the Ta 
was too high. Figure 1A and 1B depict the PCR products amplified under different PCR 
conditions. Deduced from these results, the optimal Ta were defined as summarised in table 
13. 
 
 Fig. 1A 
Fig. 1A/B: RT-PCR of different 
TLR-primers using different 
annealing temperatures for each 
primer-pair (35 amplification 
cycles). 
M = marker (GeneRulerTM 100 bp 
DNA ladder, Fermentas), + = 
cDNA, - = neg. control w/o cDNA 
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 Fig. 1B 
 
Table 13: Optimal Ta for each primer pair used in RT-PCR to detect TLR 
Primer pair Ta° Primer pair Ta° Primer pair Ta° 
TLR1 51.4°C TLR4 64.3°C TLR7 55.8°C 
TLR2 62.3°C TLR5 58.0°C TLR8 48.0°C 
TLR3 65.7°C TLR6 60.1°C TLR9 49.5°C 
 
PCR conditions evaluated in this experiment were used in all following RT-PCR experiments.  
 
6.1.2. PCR screening of buccal and sublingual cell lines for TLR 1-9 expression 
 
 
Fig. 2: PCR screening of HO-1-N-1 
cells for TLR 1-9 using 28 
amplification cycles. M = marker 
(FastRulerTM middle range DNA ladder, 
Fermentas). The results presented are 
representative of two independent 
experiments demonstrating similar 
results. 
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Analysing the expression of TLR 1-9 in the buccal cell line HO-1-N-1, best results were 
achieved after 28 amplification cycles. As seen in figure 2, mRNA coding for TLR1, TLR2, 
TLR4 and TLR6 was detected. 
Screening the sublingual cell line HO-1-u-1 for TLR 1-9, significant results were achieved 
after 30 amplification cycles. It was found that HO-1-u-1 expressed the genetic information 
for TLR1, TLR3, TLR4, TLR5 and TLR6 (Fig. 3). 
 
6.1.3. PCR screening of intestinal epithelial cell lines for TLR 1-9 expression 
 
 
 
The colorectal epithelial cell lines Caco-2/15 and Caco-2 A9 were found to express mRNA 
coding for TLR 1-9. Nonetheless, bands representing TLR3, TLR6, TLR8 and TLR9 were of 
low intensity and barely visible in the EtBr-stained agarose gel (Fig. 4). 
 
TLR10 was not tested in any of the RT-PCR experiments. 
 
Fig. 3: PCR screening of HO-1-u-1 
cells for TLR 1-9 using 30 
amplification cycles. M = marker 
(FastRulerTM middle range DNA ladder, 
Fermentas). The results presented are 
representative of two independent 
experiments demonstrating similar 
results. 
Fig. 4: PCR screening of 
Caco-2/15 and Caco-2 A9 
cells for TLRs 1-9 using 30 
amplification cycles.  
M = marker (FastRulerTM 
middle range DNA ladder, 
Fermentas). 
The results presented are 
representative of two 
independent experiments 
demonstrating similar results. 
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6.1.4. PCR screening for DC-SIGN, Dectin-1, Dectin-2, NOD1 and NOD2 
expression 
 
 
 
Analogue to the TLR experiments, RT-PCR screening was performed for the C-type lectins 
DC-SIGN, Dectin-1 and Dectin-2 and NLRs NOD1 and NOD2. 
Epithelial cell lines tested in the experiment were only positive for DC-SIGN and NOD1 (Fig. 
5). Dectin-1, Dectin-2 as well as NOD2 could not be detected by RT-PCR. 
PBMCs and DCs express RNA of all PRRs tested, namely DC-SIGN, Dectin-1, Dectin-2, 
NOD1 and NOD2, and were therefore used as positive controls. 
Interestingly, amplifying DC-SIGN cDNA of epithelial cell lines and PBMCs, seven 
transcripts could be detected on the gel. In contrast, when analysing the cDNA of the DCs, 
only one DC-SIGN transcript was amplified. 
 
6.1.5. Limitations of RT-PCR screening 
Considering the difference of the bands visible on the agarose gel in terms of intensity, it was 
supposed that some PRRs are expressed to a lower extent than others. However, RT-PCR is 
only a semi-quantitative method, and is not suitable for comparing the total amount of mRNA 
coding for a single PRR.  
Traditional RT-PCR detects the amount of replicated cDNA at the end-point of the PCR when 
the reaction has reached the plateau phase. However, this end-point is variable from sample to 
sample, which results in different quantities of amplicons at the end of the PCR even when 
Fig. 5: PCR screening for C-type 
lectins and NLRs using 30 
amplification cycles. 
M = marker (GeneRulerTM 100 bp 
DNA ladder, Fermentas), pos. 
control = PBMC and DC cDNA, 
neg. control = dH2O instead of 
cDNA. The results presented are 
representative of two independent 
experiments demonstrating similar 
results. 
 
1… DC-SIGN 
2… Dectin-1 
3… Dectin-2 
4… NOD1 
5… NOD2 
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the same amount of cDNA was used. Moreover, agarose gel resolution is very poor, and EtBr-
staining has a relatively low sensitivity. 
In qPCR, amplicated cDNA is measured at the exponential growth phase of the reaction, and 
the number of amplicons is directly proportional to an increase in reporter dye fluorescence. 
Consequently, qPCR is more sensitive than end-point PCR, and has a higher objectivity as the 
results are expressed in numbers. 
Therefore, qPCR was performed to confirm the results of RT-PCR and to quantify the relative 
amount of specific PRR mRNA expressed by the different cell lines. 
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6.2. Detection of PRR mRNA by quantitative real-time RT-PCR 
(qPCR) 
 
In order to compare the relative amounts of PRR mRNA expressed by a certain cell line, Δ Ct 
was determined, which is equal to the difference in the Ct values between the PRRs and the 
internal standard EF1 (see Materials and Methods): Δ Ct = Ct PRR – Ct EF1 
As SYBR green binds to any double stranded DNA, specificity of the amplified PCR products 
was confirmed by melting curve analysis. 
Table 14: Δ Ct values for TLR 1-10 
Δ Ct HO-1-N-1 HO-1-u-1 Caco-2/15 Caco-2 A9 PBMC DC 
TLR1 8,9 11 b 15,3 8,4 6,8 
TLR2 9 10,4 9,3 7,9 7 5,7 
TLR3 8,9 9,2 13,7 11,4 11,7 8,5 
TLR4 9,6 11,7 14 13,1 7,3 6 
TLR5 a 11,7 13,3 12,9 11,8 9,6 
TLR6 6 8 12,7 11,3 7,8 5,5 
TLR7 b 15,6 13,6 13,1 9,1 9,3 
TLR8 14,7 14,4 14,6 13,1 7,7 4,8 
TLR9 b b b b 15,1 b 
TLR10 10,7 10,3 12 11,5 8,2 10,3 
a…no specific cDNA amplified within 40 cycles; b…Ct > 35 
 
Δ Ct values evaluated for HO-1-N-1, HO-1-u-1, Caco-2/15, Caco-2 A9, PBMCs and DCs for 
TLR 1-10 are given in table 14. Hence, quantitative real-time PCR indicated that the buccal 
cell line HO-1-N-1 express TLR 1-4 and TLR6 as well as, to a lesser extent, TLR8 and 
TLR10. TLR7 and TLR9 were considered negative, as their Ct value exceeded cycle number 
35. In case of TLR5, no specific mRNA could be detected within the 40 amplification cycles 
performed. 
In the sublingual HO-1-u-1 cells, all TLRs except of TLR9 could be detected. Nevertheless, 
TLR3 and TLR6 passed the threshold at lower cycle numbers than the other receptors 
indicating a higher amount of mRNA expressed for this receptor. 
The intestinal Caco-2 cell lines seem to express mainly TLR2 mRNA. However, marginal 
amounts of mRNA were found for all TLRs except of TLR1 (in case of Caco-2/15) and 
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TLR9. Nevertheless, compared to the other cell lines, colorectal cells express lower levels of 
TLR mRNA. 
As expected, mRNA coding for TLR 1-10 was detected in PBMCs. Nevertheless, the highest 
amounts of mRNA coding for TLR 1-8 were found in DCs. They also express TLR10 but to a 
lower extent. 
 
Table 15: Δ Ct values for CLRs and NLRs 
Δ Ct HO-1-N-1 HO-1-u-1 Caco-2/15 Caco-2 A9 PBMC DC 
DC-SIGN a a a a 14,6 3,4 
Dectin-1 9,7 7,5 b b 7,4 2,7 
Dectin-2 a a 18,5 b 10,8 10,4 
NOD1 10,6 10,6 10,9 10,4 9,8 7 
NOD2 14,2 a a b 9,5 7,9 
a…no specific cDNA amplified within 40 cycles; b…Ct > 35 
 
Δ Ct values evaluated for HO-1-N-1, HO-1-u-1, Caco-2/15, Caco-2 A9, PBMCs and DCs for 
DC-SIGN, Dectin-1, Dectin-2, NOD1 and NOD2 are given in table 15. qPCR indicted that 
HO-1-N-1 cells were positive for Dectin-1, NOD1 and NOD2. HO-1-u-1 cells were only 
found positive for Dectin-1 and NOD1. In the Caco-2 cell lines, NOD1 mRNA could be 
detected, and Caco-2/15 additionally showed traces of Dectin-2 expression. PBMCs 
expressed Dectin-1, Dectin-2, NOD1 and NOD2 as well as DC-SIGN. DCs were equally 
positive for these PRR, but seem to express mainly DC-SIGN and Dectin-1 mRNA. 
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6.3. Stimulation of epithelial cell lines with PRR ligands 
 
To study the functional response of the cells to PRR ligands, epithelial cell lines were 
stimulated with PAMPs specific for the respective receptors. Recognition of PAMPs by PRRs 
result in activation of multiple intracellular signalling events and secretion of 
proinflammatory cytokines. The level of IL-8 production as a readout for the activation of 
their signalling pathway was determined by cytokine ELISA. In order to avoid false positive 
and false negative results, all ligands were tested for endotoxin contamination, and the 
viability of the activated cells was tested by [3H]-thymidine incorporation (data not shown). 
Notably, excessive basal levels of IL-8 production were observed in the oral epithelial cell 
lines HO-1-N-1 and HO-1-u-1 cells. In comparison, colorectal Caco-2 cells produced rather 
small amounts of IL-8 without any stimulus added to the culture medium. 
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Fig. 6: IL-8 production of 
the buccal cell line HO-1-
N-1 in response to 
treatment with different 
concentrations of TLR 
ligands. Values represent 
the means +/- SD of the 
results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. 
Fig. 7: IL-8 production of 
the buccal cell line HO-1-
N-1 in response to 
treatment with different 
concentrations of NLR 
and CLR ligands. Values 
represent the means +/- SD 
of the results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. 
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When challenged with different TLR stimuli, buccal HO-1-N-1 cells up-regulated IL-8 
secretion in response to Pam3CSK4, a TLR1/2 ligand, bacterial LPS, a TLR4 ligand, and to 
the TLR2/6 heterodimer agonist FSL-1 (Fig. 6). Furthermore, the NOD1 and NOD2 ligands 
iE-DAP and MDP induced increased IL-8 production in a dose-dependent manner (Fig. 7). 
No effects were observed for Poly(I:C), bacterial flagellin and R848 as well as for curdlan and 
mannan. Moreover, as already reported by Fitzner and coworkers in 2008, unmethylated CpG 
DNA had a suppressive effect on IL-8 production. 
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In the sublingual cell line HO-1-u-1, increased IL-8 secretion was observed upon stimulation 
with the TLR3 ligand Poly(I:C), the TLR5 ligand flagellin (Fig. 8), and the NOD1 ligand iE-
DAP (Fig. 9). The other PRR ligands used in the experiment did not modify IL-8 release. 
 
Fig. 8: IL-8 production of 
the sublingual cell line 
HO-1-u-1 in response to 
treatment with different 
concentrations of TLR 
ligands. Values represent 
the means +/- SD of the 
results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. 
Fig. 9: IL-8 production of 
the sublingual cell line 
HO-1-u-1 in response to 
treatment with different 
concentrations of NLR 
and CLR ligands. Values 
represent the means +/- SD 
of the results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. 
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IL-8 production in response to different TLR ligands of Caco-2/15 cells was comparable to 
that of Caco-2 A9 cells. Both intestinal cell lines showed significant up-regulation of IL-8 
secretion in response to flagellin (TLR5) and FSL-1 (TLR2/6) [Fig. 10, 11]. Besides, Caco-2 
A9 cells significantly increased IL-8 secretion in response to stimulation with Pam3CSK4 
Fig. 12: IL-8 production 
of Caco-2 cells upon 
stimulation with different 
concentrations of NLR 
and CLR ligands. Values 
represent the means +/- SD 
of the results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. Flagellin was used 
as a positive control. 
Fig. 10: IL-8 production 
of Caco-2/15 cells upon 
stimulation with different 
concentrations of TLR 
ligands. Values represent 
the means +/- SD of the 
results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. 
Fig. 11: IL-8 production 
of Caco-2 A9 cells upon 
stimulation with different 
concentrations of TLR 
ligands. Values represent 
the means +/- SD of the 
results of triplicate 
samples, and are 
representative of three 
independent experiments 
demonstrating similar 
results. 
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(TLR1/2). No significant responses were noted upon stimulation with NLR and CLR ligands 
(Fig. 12). 
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6.4. Summary 
 
Table 16: Summary of PRR expression by epithelial cell lines. 
cell type HO-1-N-1   HO-1-u-1   Caco-2/15   Caco-2 A9   
method PCR qPCR IL-8 PCR qPCR IL-8 PCR qPCR IL-8 PCR qPCR IL-8 
TLR1 ++ ++ + ++ + - + - - + (+) ++ 
TLR2 + ++ + - + - ++ ++ + ++ ++ +++ 
TLR3 - ++ - + ++ ++ + + - + + - 
TLR4 ++ ++ + ++ + - ++ + - ++ + - 
TLR5 - - - ++ + +++ ++ + +++ ++ + +++ 
TLR6 ++ ++ + ++ ++ - + + + + + +++ 
TLR7 - - - - (+) - ++ + - ++ + - 
TLR8 - + - - + - + + - + + - 
TLR9 - - - - - - + - - + - - 
TLR10 ND + ND ND + ND ND + ND ND + ND 
DC-SIGN (+) - - (+) - - (+) - - (+) - - 
Dectin-1 - ++ - - ++ - - - - - - - 
Dectin-2 - - ND - - ND - (+) ND - - ND 
NOD1 + + + + + + ++ + - + + - 
NOD2 - + +++ - - - - - - - - - 
 
PCR: 
RT-PCR: +++ strong band, ++ clear band, + weak band, (+) unspecific bands, - no band 
qPCR: +++ Δ Ct ≤ 5, ++ Δ Ct ≤ 10, + Δ Ct ≤ 15, (+) Δ Ct ≤ 20, - Δ Ct > 35 
IL-8 ELISA: 
HO-1-N-1, HO-1-u-1: +++ >2.5x, ++ 2.5–2.0x, + 2.0–1.5x, - <1.5x more IL-8 secretion than unstimulated cells 
Caco-2/15, Caco-2 A9: +++ >15x, ++ 15–10x, + 10–5x, - <5x more IL-8 secretion than unstimulated cells 
ND: not determined 
 
In summary (see table 16), we found that human buccal cells express and respond to 
stimulation of TLR1, TLR2, TLR4 and TLR6 as well as NOD1 and NOD2. Human 
sublingual cells were found to express and respond to stimulation of TLR3 and TLR5 as well 
as NOD1. Considering the Caco-2 cell lines, we observed mRNA expression and response to 
stimulation of TLR2, TLR5 and TLR6, and additionally, TLR1 in case of Caco-2 A9 cells. 
Several other PRRs were detected by PCR. However, stimulation with the respective ligands 
did not induce activation of these cells. 
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7. Discussion 
 
Epithelial cells lining the oral cavity play an important role as a physical barrier against 
microbial invasion in the mouth. Besides, several immunological elements are integrated into 
this barrier, which allow the recognition of antigens (Novak et al., 2011). During sublingual 
immunotherapy (SLIT), where allergen extracts are administered under the tongue of allergic 
patients, epithelial cells may also play an important role. However, so far the immune-
reactivity of human oral epithelia has not been well defined. Therefore, we determined PRRs 
expressed by epithelial cells of the oral cavity and evaluated their role in PAMP recognition. 
For this purpose, the expression of toll-like receptor (TLR) 1-10, C-type lectin receptors DC-
SIGN, Dectin-1 and Dectin-2 and NOD-like receptors NOD1 and NOD2 was analysed in both 
a buccal mucosa cell line, HO-1-N-1, and a sublingual epithelial cell line, HO-1-u-1. A more 
detailed knowledge of the oral mucosa will help to reveal the immunological mechanisms 
underlying SLIT of type I allergy, and consequently, to increase its efficacy. 
The term “allergy” was first introduced in 1906 by Clemens von Pirquet and is defined as a 
hypersensitivity reaction against otherwise non-infectious environmental substances called 
allergens (Galli et al., 2008). Most allergens are proteins of 5-80 kDa (Valenta, 2002), and 
some of them have enzymatic properties. However, the reason why some proteins, lipids or 
carbohydrates function as allergens is still relatively unclear. 
Type I allergy is the most common allergic/atopic disorder and is characterized by antigen-
specific IgE and a Th2-mediated immune response (Kay, 2001). During sensitization phase, 
when an atopic person first encounters a certain allergen, the allergen is taken up by APCs, 
e.g. DCs, which present peptides derived from processed allergens in combination with a 
MHC class II molecule to naïve T cells. CD4+ T cells differentiate into Th2 cells and produce 
particular cytokines such as IL-4 and IL-13. These cytokines are responsible for IgE 
production by promoting Ig class switching of specific B cells, which have also captured the 
allergen. Sensitisation leads to the establishment of allergen-specific memory B and T cells. 
Moreover, circulating IgE antibodies bind to the high-affinity IgE receptor FcεRI on mast 
cells, basophils or other APCs. Cross-linking of IgE-FcεRI complexes on mast cells and 
basophils by the multiple binding sites of an allergen leads to degranulation and subsequent 
release of biogenic amines (e.g. histamine), lipid mediators and cytokines. Binding of, for 
example, histamine to the epithelium increases vascular permeability and stimulates cell 
contraction. 
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Late-phase reactions develop 2-6 h after immediate reactions and peak 6-9 h after allergen 
exposure. They reflect the activation of allergen-specific T cells, releasing proinflammatory 
cytokines, activation of eosinophils and other mechanisms (Galli et al., 2008; Larché et al., 
2006, Kay, 2001; Valenta, 2002). 
SLIT is a non-invasive treatment to reduce clinical reactivity to allergens by repeated 
administration of high doses of the sensitising allergen under the tongue of allergic patients 
(Larché et al., 2006; Frew, 2008). The epithelium of the sublingual mucosa is thinner than 
that of other oral mucosal sites, and therefore, was chosen for allergen application (Novak et 
at., 2011). Although the underlying immunological mechanisms of SLIT are not completely 
understood, several studies have documented systemic immunological changes such as an 
enhancement of IL-10 or TGFβ-producing regulatory T cells (Bohle et al., 2007) and 
production of allergen-specific IgG, mainly the subclass IgG4 (Fanta et al., 1999; Scadding et 
al., 2010), which competes with allergen-specific IgE for allergen binding sites. 
A promising novel approach in SLIT is to apply the allergen in combination with a PAMP to 
promote allergen-specific regulatory T cells and a shift towards Th1 responses (Novak et al., 
2011). In order to use the right PAMPs, knowledge of the functional expression of PRRs by 
the oral epithelium is required. 
 
The present work shows that the buccal cell line HO-1-N-1 expressed mRNA for TLR1, 
TLR2, TLR4 and TLR6 as well as NOD1 and NOD2 and increased IL-8 synthesis in response 
to ligands specific for these receptors. TLR2 senses various components from bacteria, fungi 
or viruses. However, forming a heterodimer with TLR1 or TLR6, TLR2 recognises 
triacylated or diacylated bacterial lipopeptides, respectively. TLR4 is mainly known for 
recognition of LPS of Gram-negative bacteria (Takeuchi and Akira, 2010), and the NLRs 
NOD1 and NOD2 recognise substructures of bacterial peptidoglycan (Le Bourhis et al., 
2007). qPCR also indicated the expression of TLR3, TLR8, TLR10 and Dectin-1 in HO-1-N-
1, but the cells did not respond to stimulation with ligands specific for these receptors. 
Analysing the sublingual HO-1-u-1 cell line, mRNA coding for TLR1, TLR3, TLR4, TLR5, 
TLR6 and NOD1 was detected by end-point RT-PCR. The higher sensitivity of qPCR 
resulted in the additional detection of TLR2, TLR7, TLR8 and TLR10 and Dectin-1. 
However, HO-1-u-1 cells only responded to TLR3-, TLR5- and NOD1-specific ligands with 
increased IL-8 secretion. TLR3 recognises viral double-stranded RNA, whereas TLR5 binds 
bacterial flagellin (Takeuchi and Akira, 2010). NOD1 detects DAP-containing peptidoglycan 
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common in Gram-negative and particular Gram-positive bacteria (Chamaillard et al., 2003). 
Notably, Uehara and coworkers postulated in 2007 that HO-1-u-1 additionally expressed 
NOD2 mRNA, but the cell line did not produce any IL-8 upon PAMP stimulation. However, 
these findings are contrary to our results, as we could not detect NOD2 mRNA expression but 
observed high levels of IL-8 secretion. 
As a reference, the human epithelial colorectal adenocarcinoma cell lines Caco-2/15 and 
Caco-2 A9 were screened for the same PRRs. The results of the PCR analysis revealed that 
the colorectal epithelial cells expressed mRNA for all 10 currently known human TLRs as 
well as for NOD1. Additionally, mRNA coding for Dectin-2 was detected in Caco-2/15 by 
qPCR. Analysing the functional response of the PRRs, Caco-2 cells showed IL-8 production 
upon stimulation with ligands for TLR1/2, TLR2/6 and for TLR5. As mentioned before, 
TLR2 forms heterodimers with either TLR1 or TLR6 and thereby recognises bacterial 
lipopeptides, whereas TLR5 acts as flagellin-receptor. Hence, although these cells are 
continually exposed to commensal bacteria, they secrete proinflammatory cytokines in 
response to bacterial PAMPs. However, compared with oral epithelial cell lines, colorectal 
cells expressed lower levels of PRR mRNA and produced marginal amounts of IL-8. 
In addition, the screening revealed that the majority of PRRs were not functionally active. 
These PRRs may not be expressed on the protein level or they require other PRRs or cofactors 
for receptor function (Melmed et al., 2003). Furthermore, it was observed that the quantified 
level of PRR mRNA expression did not correlate with the responsiveness to their ligands. 
Some PRRs with a low level of mRNA expression produced relatively high amounts of IL-8 
upon stimulation (e.g. NOD2 in HO-1-N-1) and vice versa. 
 
In conclusion, it was observed that sublingual and buccal cells show differences in PRR 
expression and respond to stimulation with microbial ligands in a tissue-specific fashion. The 
spectrum of ligands, which the buccal epithelial cell line HO-1-N-1 responded to, indicates 
that these cells are basically specialised in recognising bacterial compounds. The sublingual 
epithelial cell line HO-1-u-1 responded to fewer ligands but within a broader spectrum, 
recognising viral dsRNA, bacterial flagellin and peptidoglycan. 
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7.1. Outlines 
Buccal and sublingual cell lines grown on cell culture inserts could serve as in vitro model for 
native oral epithelial cells. Therefore, the properties of HO-1-N-1 and HO-1-u-1 cells will be 
compared with those of primary epithelial cells isolated from the human oral mucosa. The 
introduction of an appropriate in vitro model would be particularly useful for further 
development of SLIT. 
Future research will also focus on the potential of using different PRR ligands as 
immunomodulators to increase the efficacy of SLIT. 
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11. Zusammenfassung 
 
Sublinguale Immuntherapie (SLIT) ist eine sichere und effektive Möglichkeit der Behandlung 
von Typ I Allergien. Die dieser Behandlung zugrunde liegenden Immunmechanismen sind 
derzeit noch nicht gänzlich aufgeklärt. Detailliertes Wissen über mögliche Immunreaktionen 
in der Mundhöhle trägt zur Aufklärung der Immunmechanismen von SLIT bei. Ziel der 
vorliegenden Masterarbeit war daher die Analyse der Expression von diversen Pathogen-
recognition Rezeptoren (PRR) auf bukkalen und sublingualen Epithelzellen. Hierfür wurden 
zwei humane Zelllinien (HO-1-N-1 bzw. HO-1-u-1) eingesetzt. Zusätzlich wurden sämtliche 
Experimente mit den gängigen intestinalen Epithelzelllinien Caco-2/15 und Caco-2 A9 
durchgeführt. 
Mittels semiquantitativer Polymerase-Kettenreaktion (polymerase chain reaction, PCR) und  
quantitativer „real-time“ PCR (qPCR) wurde die mRNA Expression der Toll-like Rezeptoren 
(TLR) 1-10, C-type Lectin Rezeptoren DC-SIGN, Dectin-1 und Dectin-2 sowie der NOD-like 
Rezeptoren NOD1 bzw. NOD2 bestimmt. Des Weiteren wurden die Zellen mit Rezeptor-
spezifischen Liganden stimuliert, und die im Falle einer Aktivierung der 
Signaltransduktionswege erhöhte Menge an ausgeschiedenem IL-8 mittels Enyzme-linked 
immunosorbent Assay (ELISA) bestimmt. 
Die bukkale Zelllinie HO-1-N-1 exprimierte mRNA für TLR1, TLR2, TLR4 und TLR6 sowie 
für NOD1 und NOD2 und reagierte auf Stimulation dieser Rezeptoren mit erhöhter IL-8 
Sekretion. Die Resultate der qPCR ließen weiters die Expression von TLR3, TLR8, TLR10 
und Dectin-1 vermuten, doch die HO-1-N-1 Zellen reagierten nicht auf die entsprechenden 
Liganden. 
Die sublinguale Zelllinie HO-1-u-1 exprimierte mRNA für TLR1, TLR3, TLR4, TLR5 und 
TLR6 sowie für NOD1. Die Resultate der qPCR ließen weiters auf Expression von TLR2, 
TLR7, TLR8, TLR10 und Dectin-1 schließen. Erhöhte IL-8 Ausschüttung konnte jedoch nur 
nach Stimulation mit TLR3-, TLR5- und NOD1-spezifischen Liganden beobachtet werden. 
Die intestinalen Caco-2/15 und Caco-2 A9 Zelllinien exprimierten mRNA für alle 10 
bekannten humanen TLRs sowie für NOD1. Zusätzlich konnte bei der Caco-2/15 Zelllinie 
Dectin-2 mRNA nachgewiesen werden. Erhöhte IL-8 Produktion wurde nach Stimulation mit 
TLR1/2-, TLR2/6- und TLR5-spezifischen Liganden gemessen. 
Zusammenfassend konnte beobachtet werden, dass bukkale und sublinguale Epithelzellen 
unterschiedliche Mustererkennungsrezeptoren exprimieren und daher auf unterschiedliche 
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Liganden reagieren. Das Liganden-Spektrum der Zelllinie HO-1-N-1 deutet darauf hin, dass 
bukkale Epithelzellen hauptsächlich auf die Erkennung von Bakterien spezialisiert sind. 
Sublinguale Epithelzellen reagieren hingegen auf eine geringere Anzahl an Liganden, dafür 
waren diese sowohl bakteriellen als auch viralen Ursprungs. 
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